ProCE Banner Activity

Considerations for Medication Adjustments in Patients With Heart Failure Initiating or Currently Taking SGLT2 Inhibitors

Clinical Thought

Read my thoughts on medication adjustments for patients with heart failure starting or currently taking SGLT2 inhibitors including diuretic dose adjustments, surgery considerations, stopping SGLT2i, and SGLT2i utilization and hypoglycemia.

Released: November 13, 2023

Share

Faculty

Lee R. Goldberg

Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA

Vice Chair of Medicine for Informatics
Section Chief, Advanced Heart Failure and Cardiac Transplant
Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

Faculty Disclosure

Primary Author

Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA

Vice Chair of Medicine for Informatics
Section Chief, Advanced Heart Failure and Cardiac Transplant
Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Lee R. Goldberg, MD, MPH, FACC, FAHA. FHFSA: consultant/advisor/speaker: Abbott, Viscardia, Zoll/Respircardia.